Page last updated: 2024-08-22
lutetium and tamoxifen
lutetium has been researched along with tamoxifen in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bal, A; Bhusari, P; Dhawan, DK; Mittal, BR; Parmar, M; Shukla, J; Singh, G; Vatsa, R | 1 |
Trials
1 trial(s) available for lutetium and tamoxifen
| Article | Year |
|---|---|
Development of Lu-177-trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients.
Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Feasibility Studies; Female; Genes, erbB-2; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Lutetium; Mastectomy; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasm Proteins; Pilot Projects; Radioimmunotherapy; Radioisotopes; Receptor, ErbB-2; Single Photon Emission Computed Tomography Computed Tomography; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tamoxifen; Tissue Distribution; Trastuzumab | 2017 |